< Back to News & Events

Boehringer Ingelheim, Evotec and bioMérieux launch AUROBAC THERAPEUTICS

Published on


The resulting company, AUROBAC THERAPEUTICS SAS, will combine the best-of-best capabilities of the three founding companies towards developing a new precision medicine approach, from diagnosis to cure.

Know more


AUROBAC THERAPEUTICS is proud to be a member of the BEAM Alliance

AUROBAC ©2024 – Legal NoticePrivacy StatementPhoto Credits